Comment submitted by Maureen Donahue Hardwick, International Pharmaceutical Aerosol Consortium

Document ID: EPA-HQ-OAR-2006-0158-0030
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: May 22 2006, at 08:21 AM Eastern Daylight Time
Date Posted: May 30 2006, at 12:00 AM Eastern Standard Time
Comment Start Date: April 11 2006, at 08:22 AM Eastern Standard Time
Comment Due Date: May 11 2006, at 11:59 PM Eastern Standard Time
Tracking Number: 8017a956
View Document:  View as format xml

Attachments:

Comment submitted by Maureen Donahue Hardwick, International Pharmaceutical Aerosol Consortium

Title:
Comment submitted by Maureen Donahue Hardwick, International Pharmaceutical Aerosol Consortium

View Attachment: View as format pdf

Related Comments

    View All
Total: 15
Comment submitted by B. Sachau
Public Submission    Posted: 04/13/2006     ID: EPA-HQ-OAR-2006-0158-0028

May 11,2006 11:59 PM ET
Comment submitted by Stephen A. Campbell, Senior Vice President, Regulatory Affairs, Amphastar Pharmaceuticals, Inc. for Armstrong Pharmaceuticals, Inc.
Public Submission    Posted: 05/14/2006     ID: EPA-HQ-OAR-2006-0158-0029

May 11,2006 11:59 PM ET
Comment submitted by Maureen Donahue Hardwick, International Pharmaceutical Aerosol Consortium
Public Submission    Posted: 05/30/2006     ID: EPA-HQ-OAR-2006-0158-0030

May 11,2006 11:59 PM ET
Comment submitted by Ronald J. Schott, Corporate Counsel, Wyeth
Public Submission    Posted: 05/30/2006     ID: EPA-HQ-OAR-2006-0158-0031

May 11,2006 11:59 PM ET
Comment submitted by Kristin D.W. Morris, Vice President, Government Affairs and Publlc Policy, Boehringer Ingelheim
Public Submission    Posted: 05/30/2006     ID: EPA-HQ-OAR-2006-0158-0034

May 11,2006 11:59 PM ET